Drug Shortage Report for TARO-TADALAFIL
Report ID | 97799 |
Drug Identification Number | 02452081 |
Brand name | RAN-TADALAFIL |
Common or Proper name | RAN-TADALAFIL |
Company Name | SUN PHARMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | TADALAFIL |
Strength(s) | 2.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 28 |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-10-25 |
Estimated end date | 2019-11-15 |
Actual end date | 2019-11-15 |
Shortage status | Resolved |
Updated date | 2019-11-26 |
Company comments | Discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-11-01 | English | Compare |
v2 | 2019-11-01 | French | Compare |
v3 | 2019-11-26 | English | Compare |
v4 | 2019-11-26 | French | Compare |
Showing 1 to 4 of 4